Covella Pharmaceuticals Overview

  • Founded
  • 2007

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Covella Pharmaceuticals General Information


Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • DE
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covella Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covella Pharmaceuticals‘s full profile, request access.

Request a free trial

Covella Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Mark Totoritis MD Co-Founder
Matthew Strobeck Ph.D Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »